Bacteriophage Therapy in Patients With Prosthetic Joint Infections

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2024

Conditions
Prosthetic Joint Infection
Interventions
BIOLOGICAL

Phage Therapy

Phage will be administered based on patient's matching results.

PROCEDURE

Two-Stage Exchange Arthroplasty

Performed per the study center's standard of care. No investigational products are used.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Adaptive Phage Therapeutics, Inc.

INDUSTRY

NCT04787250 - Bacteriophage Therapy in Patients With Prosthetic Joint Infections | Biotech Hunter | Biotech Hunter